Skip to main content
OpenTrials
Completed

NCT Number: NCT00926510

The Use of a Language Toolkit for Toddlers

To investigate whether young children with isolated expressive language delay benefit from early intervention with a simple language toolkit and brief instructions provided to their caregivers.

We hypothesize that children whose families are provided the language toolkit will develop more words over the subsequent 3 months.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Language Acquisition

Age range

14 month–19 month

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

North Carolina Children's Hospital

Chapel Hill, North Carolina, 27516, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 14.5 to 18.5 months
  • Below average expressive language
  • Otherwise normal development

Exclusion criteria

  • Other developmental delay
  • Non-English primary language

Treatment and study plan

Language toolkit

Behavioral

Simple toolkit of interactive things to stimulate language.

Safety counseling

Behavioral

Smoke detector and general safety counseling

Primary outcomes

  1. Language/Words acquisition

    Time frame: 3 months

Sponsors and collaborators

Lead sponsor

University of North Carolina, Chapel Hill

Other

Registry information

Official study title

Two to Talk: The Use of a Language Toolkit for Toddlers

Important dates

Study start
2009
Primary completion
2010
Study completion
2011
First posted
Jun 23, 2009
Registry last updated
Oct 12, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.